[1] Velasquez Reyes DC, Bloomer M, Morphet J.Prevention of central venous line associated bloodstream infections in adult intensive care units: A systematic review[J]. Intensive Crit Care Nurs, 2017, 43:12-22. [2] Pellegrini S, Rodríguez R, Lenz M, et al.Experience with ultrasound use in central venous catheterization (jugular-femoral) in pediatric patients in an intensive care unit[J]. Arch Argent Pediatr, 2022, 120(3):167-173. [3] 梁烨,林红,雷莉莉. 重症监护病房中心静脉导管相关性血流感染的高危诱发因素[J]. 中国临床研究,2018,31(12):1656-1659. [4] Harron K, Mok Q, Hughes D, et al.Generalisability and cost-impact of antibiotic-impregnated central venous catheters for reducing risk of bloodstream infection in paediatric intensive care units in England[J]. PLoS One, 2016, 11(3):e0151348. [5] 赵素民,赵贵锋,陈峰,等. 神经外科重症监护病房患者中心静脉导管相关血流感染病原菌分析[J]. 中国感染与化疗杂志,2017,17(6):629-632. [6] Hafeez SB, Ahmed A, Akhtar A, et al.Catheter-related bloodstream infection with femoral central access versus internal jugular access in patients admitting to medical intensive care unit[J]. Cureus, 2022, 14(9):e29416. [7] Velasquez Reyes DC, Bloomer M, Morphet J.Prevention of central venous line associated bloodstream infections in adult intensive care units: A systematic review[J]. Intensive Crit Care Nurs, 2017, 43:12-22. [8] Dharmayanti A, Astrawinata D.Catheter-related Blood Stream Infection in a Patient with Hemodialysis[J]. Acta Med Indones, 2018, 50(3):244-252. [9] 李婷,刘鹏,朱昱蓉. 2016—2021年重症医学科中心静脉导管相关血流感染病原菌分布及耐药性分析[J]. 检验医学与临床, 2023, 20(1): 49-53. [10] 赵素民,赵贵锋,陈峰,等. 神经外科重症监护病房患者中心静脉导管相关血流感染病原菌分析[J]. 中国感染与化疗杂志, 2017, 17(6): 629-632. [11] 崔文英. 中心静脉导管的规范化操作[J].中国血液净化, 2009, 8(2):106-109. [12] 中华医学会重症医学分会. 血管内导管相关感染的预防与治疗指南(2007)[J]. 中华内科杂志,2008,47(8):691-699. [13] 张长春,贾晓君,张淑敏,等. 中心静脉导管相关性血流感染的病原菌分布与耐药性分析[J]. 中华医院感染学杂志, 2015, 25(12): 2709-2712. [14] 张兴翔,金敏. 重症监护病房中心静脉导管相关性血流感染的病原菌分布及耐药性[J]. 中国微生态学杂志, 2016, 28(1): 76-78. [15] 时利玲,张俊霞,冯敏,等. 短期小剂量糖皮质激素在儿童难治性肺炎支原体肺炎治疗中的疗效观察[J]. 中国合理用药探索, 2017, 14(6): 36-38. [16] 叶飞,方芳,周瑜枫,等. 重症监护病房患者中心静脉导管相关性感染病原菌分布及耐药性分析[J]. 中国预防医学杂志, 2020, 21(10): 1116-1119. [17] 段会妮,姚少维. 中心静脉导管相关性血流感染病原学及危险因素分析[J]. 上海护理,2017,17(4):84-86. [18] 郭予雄,孙跃玉,钟敏泉,等. 儿科重症监护病房血管内导管相关性血流感染病原菌分布特点及耐药性分析[J]. 中华实用儿科临床杂志,2015,30(12):929-933. [19] 庄秀娟,霍开明,徐莉,等. 新生儿重症监护病房患儿经外周静脉置入中心静脉导管相关血流感染的病原菌分布及耐药性分析[J]. 中华医院感染学杂志, 2018, 28(7): 1097-1103. [20] Parlet CP,Brown MM,Horswill AR.Commensal Staphylococci influence Staphylococcus aureus skin colonization and disease[J]. Trends Microbiol, 2019, 27(6): 497-507. [21] Osaki S, Kikuchi K, Moritoki Y, et al.Distinguishing coagulase-negative Staphylococcus bacteremia from contamination using blood-culture positive bottle detection pattern and time to positivity[J]. J Infect Chemother, 2020, 26(7):672-675. [22] Yasrebi K, Schade N, Adeniyi ET.Novel effective antibacterial small-molecules against Staphylococcus and Enterococcus strains[J]. Future Med Chem, 2020, 12(4): 1205-1211. [23] Boot M, Jim KK, Liu T.A fluorescence-based reporter for monitoring expression of mycobacterial cytochrome bd in response to antibacterials and during infection[J]. Sci Rep, 2017, 7(1): 10665. [24] Rai M,Ingle AP,Pandit R.Broadening the spectrum of small-molecule antibacterials by metallic nanoparticles to overcome microbial resistance[J]. Int J Pharm, 2017. 532(1): 139-148. [25] 吴梦莹,魏艳翔,周晓燕,等. 血管内导管相关性血流感染的临床分布特征及耐药分析[J]. 中国抗生素杂志,2017,42(7):596-599. [26] De Oliveira DMP, Forde BM, Kidd TJ, et al.Antimicrobial resistance in ESKAPE pathogens[J]. Clin Microbiol Rev, 2020, 33(3):e00181-19. |